LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 363 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $275,000 | +32.2% | 4,567 | +57.9% | 0.00% | – |
| Q2 2023 | $208,000 | +2.5% | 2,892 | +4.4% | 0.00% | – |
| Q1 2023 | $203,000 | -20.7% | 2,770 | -6.6% | 0.00% | -100.0% |
| Q3 2022 | $256,000 | -3.4% | 2,967 | +0.1% | 0.00% | 0.0% |
| Q2 2022 | $265,000 | -20.4% | 2,964 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $333,000 | -29.0% | 2,964 | -2.5% | 0.00% | 0.0% |
| Q4 2021 | $469,000 | +11.9% | 3,041 | +0.6% | 0.00% | 0.0% |
| Q3 2021 | $419,000 | +6.3% | 3,023 | +0.7% | 0.00% | 0.0% |
| Q2 2021 | $394,000 | -14.0% | 3,003 | -0.3% | 0.00% | 0.0% |
| Q1 2021 | $458,000 | +48.7% | 3,012 | -2.4% | 0.00% | 0.0% |
| Q4 2020 | $308,000 | +6.2% | 3,085 | +1.4% | 0.00% | 0.0% |
| Q3 2020 | $290,000 | -15.5% | 3,043 | -9.7% | 0.00% | -50.0% |
| Q2 2020 | $343,000 | +26.1% | 3,369 | +240.3% | 0.00% | 0.0% |
| Q3 2018 | $272,000 | -55.6% | 990 | -77.9% | 0.00% | -60.0% |
| Q3 2017 | $613,000 | – | 4,474 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |